Clinical Tools MCP Server

Gestational Age ≥35 weeks

GBS Testing Already Done

Clinical Recommendation

Is The Patient Presenting With Clinical Signs Consistent With Endometriosis

Does The Patient Have Contraindications To Estrogen Containing Therapies

Is The Patient At High Risk For Bone Mineral Density Loss During Suppression Therapy

What Is The Patient Reproductive Intent And Fertility Status

Is There Evidence Of Deep Endometriosis Or Critical Organ Involvement Requiring Advanced Imaging

Does The Patient Present With Chronic Overlapping Pain Conditions Or Nociplastic Pathology

What Pharmacologic Class Is Most Appropriate Based On Symptom Profile And Contraindications

Is The Patient In A Special Population Requiring Modified Protocols

Clinical Recommendation

Is The Patient Presenting With Primary Or Secondary Amenorrhea Meeting Initial Evaluation Thresholds

Are Pregnancy And Primary Endocrine Abnormalities Present Based On Initial Laboratory Workup

Does The Patient Meet Criteria For Anatomical Or Genetic Evaluation Based On Physical Examination And Karyotype Indications

Are Specific Risk Factors For Hypothalamic Or Premature Ovarian Failure Present

Does The Patient Meet Diagnostic Criteria For Polycystic Ovary Syndrome Or Require Metabolic Screening

Is There A Need For Condition Specific Management Based On The Diagnosed Etiology

Are There Important Testing Limitations Or Clinical Caveats That Must Be Considered

Clinical Recommendation

Initial Symptomatology and Pregnancy Status Triage

VVC Subtype and Risk Factor Stratification

Trichomoniasis Diagnostic Confirmation and Resistance Assessment

BV Treatment Selection and Recurrence Management

Pregnancy-Specific Contraindication and Safety Check

Adverse Effect Monitoring and Drug Interaction Check

Final Documentation and Guideline Adaptation Check

Clinical Recommendation

What Is The Initial Clinical Presentation And Symptom Profile Category

Is The Patient Sexually Active And Does The Presentation Warrant Routine Physical Examination

Are Routine Initial Laboratory Tests Or Imaging Indicated Based On Clinical Findings

What Is The Appropriate First Line Pharmacologic Intervention Based On Patient Tolerance And Preference

Is The Patient Demonstrating Suboptimal Medication Adherence Or Delayed Dosing Patterns

Does The Patient Meet Criteria For Complementary Or Non Pharmacologic Interventions

Has The Patient Reached The Treatment Response And Escalation Threshold

What Is The Patient Fertility Desire And Surgical Candidacy Status

Clinical Recommendation

What Is The Clinical Symptom Burden And Indication For Intervention?

What Is The Patient Age And Menopausal Status With Associated Malignancy Risk Stratification?

Is There Known Or Suspected Malignancy, Pre-Cancer, Or Hereditary Cancer Syndromes Present?

What Are The Patient Fertility Goals And Uterus Preservation Preferences?

What Is The FIGO Classification, Size, And Anatomical Location Of The Fibroids?

What Is The Preoperative Hemoglobin Level And Anemia Status?

What Is The Preferred Medical Management Strategy And Are There Contraindications To Specific Agents?

What Is The Procedural Route Or Uterine-Sparing Option Selected?

What Are The Pregnancy And Fertility Implications Post-Myomectomy And Are Specific Counseling Points Required?

Clinical Recommendation

Exclusive Gateway: Are There Risk Factors For Central Sensitization Present

Exclusive Gateway: Do Musculoskeletal And Pelvic Exam Findings Indicate Myofascial Or Structural Pathology

Exclusive Gateway: Does The Primary Pain Phenotype Indicate Neuropathic Central Inflammatory Or Refractory Etiology

Exclusive Gateway: Is The Patient A Candidate For Trigger Point Nerve Block Or Advanced Interventional Therapy

Exclusive Gateway: Does The Patient Present With High Psychological Burden Functional Comorbidities Or Require Multidisciplinary Integration

Exclusive Gateway: Does The Patient Meet Surgical Candidacy Criteria Or Present With Autonomous Central Sensitization

Exclusive Gateway: Does The Post Intervention Pathway Indicate Resolution Persistence Or Complication Requiring Termination Or Escalation

Clinical Recommendation

Question: Is the primary clinical concern related to suspected Mullerian anomalies, intracavitary pathology, or unexplained infertility?

Question: Is the diagnostic imaging modality selected based on suspected Mullerian anomaly evaluation criteria?

Question: Does the identified pathology meet specific surgical indication criteria based on size, FIGO classification, or severity grading?

Question: Is the patient a candidate for post-procedural adjuvant therapy or medical management to optimize outcomes?

Question: Is the patient proceeding to assisted reproductive technology or requires obstetric monitoring following intervention?

Clinical Recommendation

Is The Patient Meeting High Risk Malignancy Criteria

Is The Patient Symptomatic Or Asymptomatic With Low Risk

Which Diagnostic Imaging Modality Is Indicated

Is Malignancy Or Premalignant Pathology Confirmed

Which Primary Management Modality Is Selected

Which Surgical Energy And Fluid Safety Parameters Apply

Which Instrument Selection For Resection Is Utilized

Which Fertility And Ivf Management Pathway Is Indicated

Clinical Recommendation

Is Chronic Pelvic Pain Persisting Greater Than Three Months Present Alongside Catamenial Exacerbation Of Core Symptoms

Does The Patient Demographic Profile Align With Known Risk Factors For Delayed Diagnosis Or Systemic Care Barriers

Do Physical Examination Findings Indicate Posterior Compartment Or Adnexal Abnormalities Requiring Specialized Mapping

Is Advanced Ultrasound Available And Appropriate For Primary Diagnostic Evaluation

Are Biomarkers Being Considered For Diagnostic Confirmation Or Risk Stratification

Is Surgical Evaluation Indicated For Diagnostic Confirmation Or Symptom Management

Do Histopathological Criteria Meet The Threshold For Definitive Endometriosis Diagnosis

Is Disease Staging Required For Multidisciplinary Communication Or Fertility Prognosis

Do Clinical Findings Warrant Referral To An Endometriosis Specialist Or Specialized Documentation Protocols

Clinical Recommendation

Is The Measured Endometrial Thickness Less Than 11 Mm

Are Clinical Or Demographic Risk Factors Present For Endometrial Pathology

Is The Patient Currently Receiving Tamoxifen Or Unopposed Estrogen Therapy

Is New Vaginal Bleeding Present In An Amenorrheic Patient On Hormone Therapy

Is Initial Endometrial Sampling Adequate

Is Cervical Stenosis Preventing Standard Sampling Access

Is Advanced Procedural Escalation Required

Is Hormonal Replacement Therapy Or Local Vaginal Therapy Indicated

Clinical Recommendation

Is the patient presenting with absolute contraindications to endometrial ablation or independent predictors of procedural failure

What is the patient physiological classification and anesthesia requirement determining the procedural setting

Which procedural modality is selected determining the intraoperative monitoring and parameter framework

What fluid type is utilized determining the critical threshold safety limits

What intraoperative complication or physiological event is occurring requiring immediate intervention

What postoperative trajectory or long-term clinical scenario is emerging

Which long-term clinical scenario or device selection factor requires final procedural adjustment

Clinical Recommendation

Is There A Selective Indication For Laparoscopy Based On Initial Infertility Evaluation Parameters

Is There A Specific Uterine Fibroid Profile Requiring Surgical Intervention

Is There A Specific Tubal Factor Profile Requiring Surgical Repair

Is There A Specific Ovarian Cyst Profile Requiring Surgical Intervention

Is There A Specific Polycystic Ovary Syndrome Profile Requiring Ovarian Drilling

Is There A Specific Pelvic Radiotherapy Profile Requiring Ovarian Transposition

Is There A Specific Endometriosis Profile Requiring Surgical Intervention

Is There A Critical Risk Factor Profile Requiring Modified Treatment Planning

Clinical Recommendation

What Is The Primary Clinical Indication And Suspected Disease Extent?

Do The Imaging Findings Meet Specific Quantitative Or Morphologic Diagnostic Thresholds?

What Reproductive, Pregnancy, Or Co-Existing Pathological Risks Are Present?

What Is The Patient Symptom Profile, Reproductive Goals, And Prior Treatment Response?

Is The Patient A Candidate For Uterine-Sparing Interventional Procedures Based On Disease Type And Fertility Goals?

Has Medical Or Interventional Therapy Failed, Or Does The Patient Require Definitive Or Uterine-Sparing Surgical Management?

Is The Patient Pursuing Fertility, And Are Preoperative Clinical Thresholds Met?

Are There Residual Diagnostic Uncertainties Or Need For Multidisciplinary Risk Stratification?

Clinical Recommendation

Is The Modified Ferriman-Gallwey Score Within Ethnic-Specific Diagnostic Thresholds

Are Clinical Signs Of Rapid Virilization Or Acute Androgen Excess Present

Is There Evidence Of Menstrual Irregularity, Galactorrhea, Or Cushingoid Features

Are There Contraindications To Combined Hormonal Contraceptives Or Antiandrogens

Is The Patient Seeking Permanent Hair Reduction Or Has Refractory Disease

Is There A Need For Specialized Imaging Or Referral Based On Lab Thresholds

Are There Specific Contraindications Or Safety Monitoring Requirements For Selected Pharmacotherapy

Is There A Requirement For Lifestyle Modification Or Cosmetic Intervention Integration

Clinical Recommendation

Is The Patient Presenting With Acute Symptoms Suggestive Of Venous Thromboembolism Or Requiring Routine Surgical Prophylaxis Evaluation

What Is The Assessed Bleeding Risk Level And Presence Of Specific Contraindications To Standard Prophylaxis

What Is The Calculated Caprini Score And Corresponding Baseline Venous Thromboembolism Risk Category

Are Specific Investigations Necessary To Diagnose The Condition Or Identify Co Occurring Conditions Before Finalizing The Treatment Plan

Does The Patient Present With Specific Comorbidities Or Special Population Factors Requiring Protocol Adjustments

Is The Patient Requiring Advanced Monitoring Safety Checks Or Discharge Preparation Before Treatment Implementation

Is The Treatment Plan Ready For Final Implementation Or Does It Require Adjustment Based On Minimally Invasive Surgery Factors

Is The Final Clinical Decision Confirmed For Implementation

Clinical Recommendation

Is The Primary Clinical Presentation Categorized By Desire, Arousal, Pain, Or Orgasm Domain Dysfunction?

Are There Risk Factors For Surgical Menopause Or Early Ovarian Failure Present?

Is The Patient Currently Taking Medications Known To Cause Sexual Dysfunction?

Is There A Confirmed History Of Breast Cancer Or Malignancy?

Is The Patient Experiencing Genitourinary Syndrome Of Menopause With Vaginal Atrophy?

Is There Evidence Of Pelvic Floor Muscular Dysfunction Or Hypertonicity?

Is There Comorbid Depression, Anxiety, Or Significant Psychosocial Distress?

Has The Patient Completed A 6-Month Therapeutic Trial With An Off-Label Intervention?

Is Testosterone Therapy Being Considered Or Actively Monitored?

Final Follow-Up And Monitoring Protocol Determination

Clinical Recommendation

Is the patient experiencing moderate to severe vasomotor symptoms

Is the patient within the safe initiation window for systemic hormone therapy

Does the patient have an intact uterus requiring endometrial protection

Are cardiovascular or venous thromboembolism risk modifiers present

Is there a history of breast cancer or absolute contraindication to systemic hormones

Are genitourinary symptoms of menopause present

Does the patient require lifestyle and nutritional intervention guidance

Has the patient been on therapy for more than three months or presents with abnormal bleeding

Clinical Recommendation

Is The Primary Clinical Presentation Bothersome Pelvic Organ Prolapse Stress Urinary Incontinence Or Both Conditions Concurrently

Are Anatomical Or Physical Predictors Of Fitting Failure Present In The Patient

Are Demographic Or Clinical Risk Factors For Unsuccessful Fitting Or Discontinuation Present

Is The Prolapse Stage Appropriate For Initial Ring Pessary Therapy Or Does It Require Advanced Support Devices

Is The Clinical Focus Primarily On Prolapse Correction Or On Incontinence Management Requiring Specific Urethral Support

Is The Patient Capable Of Performing Independent Self Care And Routine Device Removal

Are Signs Of Devascularization Erosions Infection Or Mechanical Complications Currently Present

Is The Patient Currently Pregnant Or In A Special Population Requiring Modified Management Protocols

Is There A Need For Diagnostic Or Adjunctive Testing To Unmask Latent Conditions Or Evaluate Postoperative Outcomes

Clinical Recommendation

Is The Initial Clinical Presentation Consistent With A Specific Vulvar Dermatosus Or Atypical Lesion

Does The Patient Demographic Profile And Comorbid History Indicate Specific Epidemiological Risk Factors Or Contraindications

Do Investigation Results And Diagnostic Testing Confirm The Suspected Etiology Or Require Technique Specific Sampling

Which Condition Specific Treatment Pathway Matches The Confirmed Diagnosis And Severity Stratification

Does The Treatment Response And Time Elapsed Warrant Escalation Monitoring Or Maintenance Adjustment

Do Adjunctive Symptoms Or Counseling Requirements Necessitate Specialized Supportive Interventions

Final Verification Of Safety Parameters And Contraindication Clearance Before Discharge

Clinical Recommendation

Is The Patient Presenting With Symptomatic Genitourinary Syndrome Of Menopause Indicators

Are There Specific Predisposing Conditions Or Exacerbating Risk Factors Present

Are Diagnostic Investigations And Physical Examination Criteria Met For Confirmation

Is The Patient A Candidate For First-Line Non-Hormonal Management Strategies

Which Second-Line Therapeutic Pathway Is Indicated Based On Symptom Profile And Contraindications

Does The Patient Belong To A Special Population Requiring Specific Safety Protocols

Are Third-Line Procedural Interventions Indicated Based On Treatment Failure Or Patient Decline

Is The Patient Entering The Monitoring And Follow-Up Phase For Therapeutic Adjustment

Clinical Recommendation

Gateway 1: Does The Patient Present With Acute Symptoms, Chronic Vague Symptoms, Or No Symptoms?

Gateway 2: Is The Patient Age Eighteen Years Or Older And Does The Patient Have A High-Risk Personal History Or High-Risk Family History?

Gateway 3: Does The Patient Meet Mandatory Sonographic Referral Criteria Or Present With Indeterminate Bilateral Masses?

Gateway 4: Does The Ultrasound Imaging Demonstrate Malignant Features, Benign Features, Or Indeterminate Features According To Iota Simple Rules?

Gateway 5: Does The Patient Meet Criteria For Specific Tumor Marker Panels Based On Age, Mass Characteristics, Or Suspected Origin?

Gateway 6: Is The Risk Of Malignancy Index Or Alternative Biomarker Index Applicable And What Is The Calculated Threshold Or Clinical Note?

Gateway 7: What Is The Recommended Management Pathway Based On The Final Classification And Investigation Results?

Clinical Recommendation

Is The Pain Temporally Related To Menses With Classic Primary Dysmenorrhea Features?

Are Modifiable And Non-Modifiable Risk Factors Present?

Do Mandatory History Taking Parameters Indicate Need For Targeted Evaluation?

Is An Initial Pelvic Examination Indicated?

Are Routine Imaging Or Laboratory Protocols Indicated Based On Clinical Findings?

Which First-Line Non-Hormonal Therapy Protocol Should Be Initiated?

Which First-Line Hormonal Therapy Regimen Is Appropriate?

Should Complementary And Adjunctive Therapies Be Integrated?

Are Surgical Management Indications Met?

Do Monitoring And Escalation Criteria Warrant Referral Or Chronic Pain Prevention Strategies?

Clinical Recommendation

Initial Symptom Domain Assessment

High-Risk History and Vulnerability Assessment

Clinical Threshold and Immediate Referral Assessment

Diagnostic Workup and Rule-Out Assessment

Mood and Depression Management Strategy

Sleep Disturbance Management Strategy

Cognitive Concern and Vascular Risk Management Strategy

Pharmacotherapy Safety and Dosing Selection

Clinical Recommendation

Is The Hemoglobin Level Below The Diagnostic Threshold For Iron Deficiency Anemia

Which Comprehensive Set Of Risk Factors Is Present To Influence Treatment Contraindications And Monitoring Needs

Which Specific Screening Protocol Or Investigation Timeline Applies To The Current Clinical Context

What Is The Severity Of Anemia And Which Clinical Indicators Dictate The Primary Treatment Modality

Which Intravenous Iron Formulation And Maximum Dosing Regimen Matches The Patient Gravid Status And Clinical Needs

What Type Of Adverse Reaction Or Monitoring Priority Requires Immediate Clinical Intervention During Intravenous Iron Administration

What Oral Iron Regimen And Dietary Optimization Strategy Is Appropriate Based On Tolerance And Formulation Requirements

Which Post-Treatment Monitoring Timeline And Duration Requirement Applies To The Selected Therapy

Clinical Recommendation

Are acute symptoms or signs of an ovarian mass complication present?

Is ovarian torsion suspected or confirmed?

What is the menopausal status of a patient with suspected torsion?

Are operative indications present in an acute non torsion presentation?

Does the ultrasound demonstrate a classic benign ovarian morphology?

Are chronic symptomatic ovarian mass parameters present in a patient with classic benign morphology?

What is the menopausal status of a symptomatic patient with classic benign morphology?

What asymptomatic benign mass risk profile is present?

What hormonal management status applies to the patient?

Is malignancy suspected based on clinical, imaging, or biomarker parameters?

Clinical Recommendation

Enhanced Clinical Tools MCP Server

Available Clinical Decision Support Tools:

Gynecology Tools:

cervical_cancer_screening - Cervical cancer screening recommendations
fibroid_management_tool - Fibroid/leiomyoma management options
dysmenorrhea_management_tool - Pelvic pain and dysmenorrhea management

Obstetrics Tools:

didi_twins_tool - Dichorionic diamniotic twin management
gbs_tool - Group B Streptococcus prophylaxis screening
gdm_tool - Gestational diabetes testing
hcv_prenatal_screening_tool - Hepatitis C prenatal screening
icp_tool - Intrahepatic cholestasis of pregnancy management
pertussis_tool - Pertussis vaccination eligibility
pregnancy_calculator_tool - Pregnancy date calculations
prenatal_genetic_screening_tool - Prenatal genetic screening for aneuploidy
rhig_tool - RhoGAM immunoglobulin eligibility

Mental Health Tools:

mental_health_meds_tool - Mental health medication options
mental_health_screen_tool - Prenatal depression/anxiety screening

General Tools:

risk_factor_tool - Risk factor assessment and counselling

All tools call clinical decision support APIs and return evidence-based recommendations.

⚠️ Important: All recommendations should be reviewed by qualified healthcare professionals and considered alongside complete patient history and clinical judgment.

MCP Connection Info:

Server URL: https://gjacob2010-mcp-server-r02.hf.space
Transport: SSE (Server-Sent Events)
Compatible with: LM Studio, Claude Desktop, and other MCP-compatible clients

🏥 Clinical Tools MCP Server

Enhanced Clinical Tools MCP Server

Gynecology Tools:

Obstetrics Tools:

Mental Health Tools:

General Tools: